Designation of people with intellectual and developmental disabilities as a medically underserved population would not solve problems of access to care.

Women with disabilities may be prevented access to reproductive medicine due to discrimination and mistaken assumptions about disabled people.

Carefully distinguishing between when the Nazi analogy is aptly applied and when it is not is key to ongoing PAD legalization deliberations.

Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.

Physicians must resist judging the quality of life of their patients with Down syndrome and learn to listen and see them as individual personalities.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

Workplace wellness programs contribute to the wellness movement by enlisting nontraditional health partners and influencing social determinants of health.

Medical expert witnesses are ethically and legally obligated to provide honest testimony that meets the standards of the Daubert test.